These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 14604889

  • 21. c-Myc-regulated microRNAs modulate E2F1 expression.
    O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT.
    Nature; 2005 Jun 09; 435(7043):839-43. PubMed ID: 15944709
    [Abstract] [Full Text] [Related]

  • 22. Antisense to cyclin D1 inhibits vascular endothelial growth factor-stimulated growth of vascular endothelial cells: implication of tumor vascularization.
    Yasui M, Yamamoto H, Ngan CY, Damdinsuren B, Sugita Y, Fukunaga H, Gu J, Maeda M, Takemasa I, Ikeda M, Fujio Y, Sekimoto M, Matsuura N, Weinstein IB, Monden M.
    Clin Cancer Res; 2006 Aug 01; 12(15):4720-9. PubMed ID: 16899623
    [Abstract] [Full Text] [Related]

  • 23. Transduction of antisense cyclin D1 using two-step gene transfer inhibits the growth of rat hepatoma cells.
    Uto H, Ido A, Moriuchi A, Onaga Y, Nagata K, Onaga M, Tahara Y, Hori T, Hirono S, Hayashi K, Tsubouchi H.
    Cancer Res; 2001 Jun 15; 61(12):4779-83. PubMed ID: 11406552
    [Abstract] [Full Text] [Related]

  • 24. Hepatocyte growth factor induces pro-apoptotic genes in HepG2 hepatoma but not in B16-F1 melanoma cells.
    Matteucci E, Castoldi R, Desiderio MA.
    J Cell Physiol; 2001 Mar 15; 186(3):387-96. PubMed ID: 11169978
    [Abstract] [Full Text] [Related]

  • 25. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1.
    Mawson A, Lai A, Carroll JS, Sergio CM, Mitchell CJ, Sarcevic B.
    Mol Cell Endocrinol; 2005 Jan 14; 229(1-2):161-73. PubMed ID: 15607540
    [Abstract] [Full Text] [Related]

  • 26. Control of cyclin D1 expression by antisense oligonucleotides in three ovarian cancer cell lines.
    Cagnoli M, Barbieri F, Bruzzo C, Alama A.
    Gynecol Oncol; 1998 Sep 14; 70(3):372-7. PubMed ID: 9790790
    [Abstract] [Full Text] [Related]

  • 27. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.
    Saiz AD, Olvera M, Rezk S, Florentine BA, McCourty A, Brynes RK.
    J Pathol; 2002 Oct 14; 198(2):157-62. PubMed ID: 12237874
    [Abstract] [Full Text] [Related]

  • 28. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
    Tomari K, Kumagai T, Shimizu T, Takeda K.
    Int J Mol Med; 2005 Feb 14; 15(2):253-8. PubMed ID: 15647840
    [Abstract] [Full Text] [Related]

  • 29. PARP-1 binds E2F-1 independently of its DNA binding and catalytic domains, and acts as a novel coactivator of E2F-1-mediated transcription during re-entry of quiescent cells into S phase.
    Simbulan-Rosenthal CM, Rosenthal DS, Luo R, Samara R, Espinoza LA, Hassa PO, Hottiger MO, Smulson ME.
    Oncogene; 2003 Nov 20; 22(52):8460-71. PubMed ID: 14627987
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.
    Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG.
    Cancer Res; 2002 Jun 01; 62(11):3276-81. PubMed ID: 12036945
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Inhibition of hepatitis C virus core protein expression in immortalized human hepatocytes induces cytochrome c-independent increase in Apaf-1 and caspase-9 activation for cell death.
    Meyer K, Basu A, Saito K, Ray RB, Ray R.
    Virology; 2005 Jun 05; 336(2):198-207. PubMed ID: 15892961
    [Abstract] [Full Text] [Related]

  • 34. Delta 9-tetrahydrocannabinol inhibits cell cycle progression by downregulation of E2F1 in human glioblastoma multiforme cells.
    Galanti G, Fisher T, Kventsel I, Shoham J, Gallily R, Mechoulam R, Lavie G, Amariglio N, Rechavi G, Toren A.
    Acta Oncol; 2008 Jun 05; 47(6):1062-70. PubMed ID: 17934890
    [Abstract] [Full Text] [Related]

  • 35. Cyclin B and E2F-1 expression in prostate carcinoma cells treated with the novel retinoid CD437 are regulated by the ubiquitin-mediated pathway.
    Farhana L, Dawson M, Rishi AK, Zhang Y, Van Buren E, Trivedi C, Reichert U, Fang G, Kirschner MW, Fontana JA.
    Cancer Res; 2002 Jul 01; 62(13):3842-9. PubMed ID: 12097298
    [Abstract] [Full Text] [Related]

  • 36. E2F1 messenger RNA is destabilized in response to a growth inhibitor in normal human keratinocytes but not in a squamous carcinoma cell line.
    Saunders NA, Dicker AJ, Jones SJ, Dahler AL.
    Cancer Res; 1998 Apr 15; 58(8):1646-9. PubMed ID: 9563476
    [Abstract] [Full Text] [Related]

  • 37. Myc and E2F1 induce p53 through p14ARF-independent mechanisms in human fibroblasts.
    Lindström MS, Wiman KG.
    Oncogene; 2003 Aug 07; 22(32):4993-5005. PubMed ID: 12902982
    [Abstract] [Full Text] [Related]

  • 38. Tumor suppression by IFN regulatory factor-1 is mediated by transcriptional down-regulation of cyclin D1.
    Kröger A, Stirnweiss A, Pulverer JE, Klages K, Grashoff M, Reimann J, Hauser H.
    Cancer Res; 2007 Apr 01; 67(7):2972-81. PubMed ID: 17409403
    [Abstract] [Full Text] [Related]

  • 39. E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.
    Garneau H, Paquin MC, Carrier JC, Rivard N.
    J Cell Physiol; 2009 Nov 01; 221(2):350-8. PubMed ID: 19562678
    [Abstract] [Full Text] [Related]

  • 40. Distinct pattern of E2F1 expression in human lung tumours: E2F1 is upregulated in small cell lung carcinoma.
    Eymin B, Gazzeri S, Brambilla C, Brambilla E.
    Oncogene; 2001 Mar 29; 20(14):1678-87. PubMed ID: 11313916
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.